Home›Search›Experimental and Molecular Medicine

Experimental and Molecular Medicine

Springer Nature · United Kingdom · Est. 1955

ISSN1226-3613eISSN2092-6413

SJR Q1✓ WOS SCIE✓ Scopus / SJR✓ DOAJ✓ Open Access

100

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (4 more)+22

Total100

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

weeks to publish · journal-reported

Fast · vs ~15 wk median

SJR Rank

Top 25% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei

5.123

H-Indexi

174

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

2.322

Total Worksi

3,713

Total Citationsi

172,428

2yr Mean Citednessi

11.85

Open Impact Factor alternative

Aims & Scope

Experimental & Molecular Medicine (EMM) is Korea's first biochemistry journal (founded in 1964) and is relaunched in 1996 as an Open Access, fully peer-reviewed international journal. It is a medical research journal devoted to publishing the latest developments in translational research and the recent discoveries in the biomedical field. Submission is encouraged of papers that involve genetic, molecular and cellular studies of human physiology and diseases. The journal seeks to highlight the improved clinical benefits for human health from experimental and translational research performed using specific molecular tools. Studies that encompass basic discoveries with clinical relevance as well as articles dealing with clear in vivo relevance and novelty will also be welcomed. Experimental & Molecular Medicine is an open access, online-only journal. Topics of particular interest within the journal's scope include, but are not limited to, those listed below: Cancer biology Immunology Neuroscience Cardiovascular biology Genetics and genomics Gene therapy Metabolic diseases Stem cells and regenerative medicine Physiology and diseases Molecular Medicine

General Information

Country / RegionUnited Kingdom

Primary LanguageEnglish

1st Year Published1955

Frequencydaily

StatusActive (last: 2026)

Total Publications3,713

Publisher OrgSpringer Nature

OA Since1995

Visit Journal Website

Submission Info

Peer ReviewSingle-blind

Review Time~5 weeks

Acceptance Rate—

OA LicenseCC BY

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

9/12 · 75%

✅

Do you know the journal / publisher?

Springer Nature

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1226-3613 / 2092-6413

✅

Indexed in a trusted database?

WoS, Scopus, DOAJ, PubMed

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

163

14k

2019

186

22k

2020

169

11k

2021

193

11k

2022

227

11k

2023

236

6.4k

2024

240

1.9k

2025

160

102

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

BiochemistryQ1

Clinical BiochemistryQ1

Medicine (miscellaneous)Q1

Molecular BiologyQ1

Molecular MedicineQ1

Subject Classification

Web of Science Categories

Biochemistry & Molecular BiologyMedicine, Research & Experimental

Scopus Categories

BiochemistryClinical BiochemistryMedicine (miscellaneous)Molecular MedicineMolecular Biology

Research Topics (OpenAlex)

RNA modifications and cancerEpigenetics and DNA MethylationCancer, Hypoxia, and MetabolismImmune Cell Function and InteractionMicroRNA in disease regulationPancreatic function and diabetesCancer-related molecular mechanisms researchAdipose Tissue and MetabolismRNA Research and SplicingCancer-related gene regulation

Frequently asked questions about Experimental and Molecular Medicine

Is Experimental and Molecular Medicine a predatory journal?

PubScope has no integrity flags on record for Experimental and Molecular Medicine: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 100/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Experimental and Molecular Medicine?

Experimental and Molecular Medicine is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 11.85.

Is Experimental and Molecular Medicine indexed in Scopus and Web of Science?

Experimental and Molecular Medicine is indexed in Web of Science, Scopus, DOAJ.